title: Exploring the correlates of intermediate CAG repeats in Huntington disease.
abstract: OBJECTIVE
  To explore the clinical phenotype in individuals with huntingtin gene CAG repeat lengths between 27 and 35, a range that is termed "intermediate" and below one traditionally considered diagnostic of Huntington disease (HD).
  
  
  BACKGROUND
  The Prospective Huntington Disease At-Risk Observational Study (PHAROS) found that patients with intermediate CAG lengths overlapped with those diagnosed as HD (≥ 37 CAG repeats) on the Unified Huntington's Disease Rating Scale (UHDRS) behavioral measures. Furthermore, several patients with intermediate CAG repeats demonstrating clinical (and pathological) evidence of HD have been reported.
  
  
  METHODS
  We reviewed all cases with intermediate CAG repeats who have presented to our clinic, as well as those reported in the literature.
  
  
  RESULTS
  We describe 4 patients with intermediate repeats evaluated at our center whose clinical features were highly suggestive of HD. Investigations for HD phenocopies were negative. Anticipation was demonstrated in 1 case with supportive neuropathological evidence of HD. Additionally, we describe the clinical features of 5 other patients reported in the literature.
  
  
  CONCLUSIONS
  Individuals with huntingtin gene CAG repeats in the intermediate (27-35) range should be considered at risk for the development of HD, particularly if they have a family history of HD, whether they exhibit clinical features of the disease.
authors: Parkinson's Disease Center and Movement Disorders Clinic, Department of Neurology, Baylor College of Medicine, Houston, TX 77030, USA.
authors: Ainhi D
authors: AD
authors: Ha
authors: Joseph
authors: J
authors: Jankovic
mesh_terms: D017668:Age of Onset; D000368:Aged; D000483:Alleles; D005260:Female; D006801:Humans; D006816:Huntington Disease / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D012307:Risk Factors; D018911:Trinucleotide Repeats / Q000235:genetics*